Abstract
This editorial comments upon an article that focuses on an assessment of the relative usefulness of virologic and immunologic markers in predicting mortality among HIV-infected women in Nairobi Kenya during 1-2 years of follow-up after delivery. It states that the article is encouraging because it indicates that CD4 cell counts can be used to make decisions about treatment and monitoring of HIV disease progression in resource-limited settings where virologic monitoring is not widely available.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
